These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7662775)

  • 1. PAS-Port: a new implantable vascular access device for arm placement: experiences from the first two years.
    Lundberg G; Wahlberg E; Rickberg A; Olofsson P
    Eur J Surg; 1995 May; 161(5):323-6. PubMed ID: 7662775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiologic placement of a low profile implantable venous access port in a pediatric population.
    Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA
    Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chest port placement with use of the single-incision insertion technique.
    Charles HW; Miguel T; Kovacs S; Gohari A; Arampulikan J; McCann JW
    J Vasc Interv Radiol; 2009 Nov; 20(11):1464-9. PubMed ID: 19875065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripherally-placed central venous access ports: clinical and laboratory observations.
    Johnson JA; Didlake RH
    Am Surg; 1994 Dec; 60(12):915-9. PubMed ID: 7992964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of totally implantable systems for long-term vascular access in the treatment of the neoplastic patient].
    Aldrighetti L; Caterini R; Ronzoni M; Jannello A; Ferla G
    Minerva Chir; 1995 May; 50(5):447-54. PubMed ID: 7478055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A safe and simple method of percutaneous transfemoral implantation of a port-catheter access system for hepatic artery chemotherapy infusion].
    Kuroiwa T; Honda H; Yoshimitsu K; Irie H; Aibe H; Shinozaki K; Nishie A; Nakayama T; Masuda K
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1573-7. PubMed ID: 11707983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical outcome of totally implantable subcutaneous infusion port--comparison with home parenteral nutrition and chemotherapy].
    Taniguchi K; Oka K; Tokuyasu N; Naka T; Kondo A; Tsujitani S; Ikeguchi M
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):281-5. PubMed ID: 18281766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications associated with an implantable vascular access device.
    Dillon PA; Foglia RP
    J Pediatr Surg; 2006 Sep; 41(9):1582-7. PubMed ID: 16952595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports.
    Carlo JT; Lamont JP; McCarty TM; Livingston S; Kuhn JA
    Am J Surg; 2004 Dec; 188(6):722-7. PubMed ID: 15619490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis.
    Schwarz RE; Groeger JS; Coit DG
    Cancer; 1997 Apr; 79(8):1635-40. PubMed ID: 9118051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Subcutaneous chamber systems (ports) for long-term care in cancer patients].
    Hájek R; Sevcík P; Ondrásek J; Mayer J; Vásová I; Král Z; Tomíska M; Krahulcová E; Penka M; Kubesová H
    Vnitr Lek; 1995 Jan; 41(1):21-7. PubMed ID: 7716888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre.
    Narducci F; Jean-Laurent M; Boulanger L; El Bédoui S; Mallet Y; Houpeau JL; Hamdani A; Penel N; Fournier C
    Eur J Surg Oncol; 2011 Oct; 37(10):913-8. PubMed ID: 21831566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathlink 20: a subcutaneous implanted central venous access device used in children with sickle cell disease on long-term erythrocytapheresis--a report of low complication rates.
    Raj A; Bertolone S; Bond S; Burnett D; Denker A
    Pediatr Blood Cancer; 2005 Jun; 44(7):669-72. PubMed ID: 15700248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual complications of the subcutaneous port catheter.
    Eroğlu E; Bulutçu E; Erçelen O
    N Z Med J; 2008 Aug; 121(1280):15-8. PubMed ID: 18791623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Percutaneous implant of Hickman catheters and reservoirs. Long-term experience].
    Carreira Villamor JM; Reyes Pérez R; Pulido-Duque JM; Gorriz Gómez E; Pardo MD; Argiles Vives JM; Eyheremendy EP; Maynar Moliner M
    Rev Clin Esp; 1997 Nov; 197(11):740-4. PubMed ID: 9547192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with the intravenous totally implanted port in patients with gynecologic malignancies.
    Nelson BE; Mayer AR; Tseng PC; Schwartz PE
    Gynecol Oncol; 1994 Apr; 53(1):98-102. PubMed ID: 8175028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral ports are a new option for central venous access.
    Schuman E; Ragsdale J
    J Am Coll Surg; 1995 Apr; 180(4):456-60. PubMed ID: 7719550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between peripherally implanted ports and externally sited catheters for long-term venous access.
    Pullyblank AM; Carey PD; Pearce SZ; Tanner AG; Guillou PJ; Monson JR
    Ann R Coll Surg Engl; 1994 Jan; 76(1):33-8. PubMed ID: 8117017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of subcutaneous implantable infusion systems in neoplastic and AIDS patients requiring long-term venous access.
    Dionigi P; Cebrelli T; Jemos V; Minoli L; Gobbi P; Dimitrov G
    Eur J Surg; 1995 Feb; 161(2):137-42. PubMed ID: 7772631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A trial with a new peripheral implanted vascular access device.
    Winters V; Peters B; Coilá S; Jones L
    Oncol Nurs Forum; 1990; 17(6):891-6. PubMed ID: 2263515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.